misonidazole has been researched along with HPV Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Binns, D; Bressel, M; Corry, J; Fisher, R; Hicks, RJ; McArthur, GA; Peters, LJ; Rischin, D; Solomon, B; Trinkaus, ME; Young, RJ | 1 |
Porceddu, SV | 1 |
Bittner, MI; Bucher, S; Grosu, AL; Hentschel, M; Kayser, G; Meyer, PT; Mix, M; Rücker, G; Weber, WA; Werner, M; Wiedenmann, N | 1 |
1 trial(s) available for misonidazole and HPV Infection
Article | Year |
---|---|
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Hypoxia; Cyclin-Dependent Kinase Inhibitor p16; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Neoplasm Proteins; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2014 |
2 other study(ies) available for misonidazole and HPV Infection
Article | Year |
---|---|
Insights into the relationship between HPV/p16 status, hypoxia imaging and treatment outcomes in head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Hypoxia; Cyclin-Dependent Kinase Inhibitor p16; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Neoplasm Proteins; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2014 |
Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.
Topics: Adult; Aged; Biomarkers, Tumor; Carbonic Anhydrase IX; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunohistochemistry; Ku Autoantigen; Male; Middle Aged; Misonidazole; Papillomavirus Infections; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Hypoxia | 2016 |